π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
75-80% of NSCLC are diagnosed at the metastatic stage. Among the most frequ...
Status
Active Not Recruiting
Location
CHU de Bordeaux
Start Date
2025-01-01
Trial ID
NCT07389642
Treatments Being Tested
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel drug de...
Status
Suspended
Location
National Cancer Center Singapore
Start Date
2021-05-20
Trial ID
NCT04956068
Treatments Being Tested
Systemic sclerosis (SSc, AKA scleroderma) is an autoimmune condition charac...
Status
Unknown
Location
University Medical Center-New Orleans
Start Date
2018-06-01
Trial ID
NCT03459716
Treatments Being Tested
This research is a prospective, multi-center, single-arm clinical trial aim...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-12-11
Trial ID
NCT06743867
Treatments Being Tested
Systemic sclerosis (SSc) is a rare and potentially life-threatening autoimm...
Status
Completed
Location
Rheumtoi Unit, Academic Hospital Careggi
Start Date
2020-06-01
Trial ID
NCT04212247
Treatments Being Tested
Irreversible electroporation (IRE) is a promising new ablation technique to...
Status
Completed
Location
Bart Geboers
Start Date
2016-05-30
Trial ID
NCT02791503
Treatments Being Tested
This study focused on exploring new comprehensive treatment strategies for ...
Status
Recruiting
Location
Zhongda Hospital
Start Date
2024-12-31
Trial ID
NCT06849180
Treatments Being Tested
Type A aortic dissection (TAAD) is a potentially life-threatening pathology...
Status
Enrolling By Invitation
Location
Francesco Nappi
Start Date
2005-01-01
Trial ID
NCT05927090
Treatments Being Tested
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Status
Recruiting
Location
University of Florida
Start Date
2016-04-11
Trial ID
NCT02735707
Treatments Being Tested
The purpose of this study is to expand access to medications for opioid use...
Status
Completed
Location
Washington State Healthcare Authority
Start Date
2022-03-14
Trial ID
NCT05343793